363 related articles for article (PubMed ID: 10806684)
1. [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].
Li D; Li C; Zhu Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):597-600. PubMed ID: 10806684
[TBL] [Abstract][Full Text] [Related]
2. [Immuno-epidemiological investigation of recurrent spontaneous abortion].
Li D; Zhu Y; Wang M
Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):94-7. PubMed ID: 10923415
[TBL] [Abstract][Full Text] [Related]
3. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
Pandey MK; Agrawal S
Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
[TBL] [Abstract][Full Text] [Related]
4. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
[TBL] [Abstract][Full Text] [Related]
5. Analysis of anti-lymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes.
Gilman-Sachs A; Luo SP; Beer AE; Beaman KD
J Clin Lab Immunol; 1989 Oct; 30(2):53-9. PubMed ID: 2534916
[TBL] [Abstract][Full Text] [Related]
6. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
[TBL] [Abstract][Full Text] [Related]
7. [Maternal immune responses induced by the immunotherapy in patients with recurrent spontaneous abortions].
Sugi T; Makino T; Toyoshima K; Sakai A; Maruyama T; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):173-8. PubMed ID: 2013705
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing success rate of leukocyte immunization and anti-paternal antibodies in spontaneous recurrent miscarriage.
Chaichian S; Shoaee S; Saremi A; Pedar S; Firouzi F
Am J Reprod Immunol; 2007 Mar; 57(3):169-76. PubMed ID: 17295895
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
Beer AE; Semprini AE; Zhu XY; Quebbeman JF
Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
[TBL] [Abstract][Full Text] [Related]
10. The results of investigations for blocking antibody and autoantibodies help to choose between different immunological treatments for recurrent abortion.
Unander AM; Norberg R; Wenneström H; Siösteen C; Lindholm A; Stigendal L; Haeger M; Arfors L
Acta Eur Fertil; 1989; 20(4):193-8. PubMed ID: 2535267
[TBL] [Abstract][Full Text] [Related]
11. [Study on positive rate of blocking antibody in women with recurrent spontaneous abortion administered by route and frequency of paternal lymphocyte immunotherapy].
Yu HL; Deng XH; Chao L; Chen C; Han YL
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):903-6. PubMed ID: 24495682
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA).
Gharesi-Fard B; Zolghadri J; Foroughinia L; Tavazoo F; Samsami Dehaghani A
Iran J Immunol; 2007 Sep; 4(3):173-8. PubMed ID: 17767017
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy and neonatal outcomes in unexplained recurrent/habitual aborters treated by allogenic leukocyte immunization.
Tanaka T; Umesaki N; Maeda K; Miyama M; Ogita S
Osaka City Med J; 1997 Jun; 43(1):81-7. PubMed ID: 9343997
[TBL] [Abstract][Full Text] [Related]
14. Paternal leucocyte immunotherapy for recurrent pregnancy loss.
Agrawal S; Kishore R
Natl Med J India; 1995; 8(3):121-3. PubMed ID: 7780352
[TBL] [Abstract][Full Text] [Related]
15. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome.
Smith JB; Cowchock FS
J Reprod Immunol; 1988 Nov; 14(2):99-113. PubMed ID: 2976829
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion.
Pandey MK; Thakur S; Agrawal S
Arch Gynecol Obstet; 2004 Mar; 269(3):161-72. PubMed ID: 14652774
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on the CTL-p frequency before and after immunotherapy for patients with unexplained habitual abortion].
Yamada K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jun; 45(6):527-32. PubMed ID: 8315311
[TBL] [Abstract][Full Text] [Related]
18. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.
Clark DA
Am J Reprod Immunol; 2009 Jan; 61(1):75-84. PubMed ID: 19086995
[TBL] [Abstract][Full Text] [Related]
19. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
[TBL] [Abstract][Full Text] [Related]
20. [Passive immunotherapy with polyvalent immunoglobulins in women with habitual abortions].
Mueller-Eckhardt G; Heine O; Turba H; Berghöfer A; Neppert J; Künzel W; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():298-301. PubMed ID: 1703857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
